{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"}],"units":"Participants"}],"description":"Grading of AE's is performed using the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.","groups":[{"description":"All patients who receive transplant in the phase 1+2 of the study","id":"OG000","title":"Patients Undergoing Transplantation"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Up to 4 1/2 months","title":"Frequency of Grades 3 and 4 Non-hematologic Adverse Events During the Transplant Component ( 135 Days)","type":"PRIMARY","unitOfMeasure":"Participants"}